Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlpha Group International Regulatory News (ALPH)

Share Price Information for Alpha Group International (ALPH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,100.00
Bid: 2,070.00
Ask: 2,080.00
Change: 0.00 (0.00%)
Spread: 10.00 (0.483%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 2,100.00
ALPH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Share Schemes

26 Apr 2024 11:00

RNS Number : 2271M
Alpha Group International PLC
26 April 2024
 

26 April 2024

Alpha Group International plc

 

("Alpha" or the "Company")

 

New Share Schemes

 

Alpha Group International plc (AIM: ALPH), a high-tech, high-touch provider of financial solutions, dedicated to corporates and institutions operating internationally, today wishes to provide an update with regard to changes to the Group's Employee Share Schemes. 

 

J Share Growth Scheme

 

The Group will be adopting a growth share scheme, in addition to and on similar terms to the existing F Share Growth Scheme under which 550 ordinary shares ("J Shares") in Alpha FX Limited will be issued in total to certain employees of the Group ("J Share Growth Scheme").

 

The J Shares contain a put option, allowing the holder to convert their J shares into ordinary shares in Alpha. The J Shares allocated to each employee will vest in five equal tranches, occurring annually, in respect of the Financial Years for 2024, 2025, 2026, 2027 and 2028, subject to the Group achieving the target growth rates for that year. The relevant target growth rates are as follows:- Group revenue growth of 20% in Financial Year 2024, 20% in Financial Year 2025, 20% in Financial Year 2026, 15% in Financial Year 2027 and 15% in Financial Year 2028. Once vested the employee has the right to exercise their put option to convert their J shares into ordinary shares of Alpha. The number of ordinary shares of Alpha issued to the employees is calculated by dividing the value of the employee's holding of J shares by the average of the closing price of Alpha over 60 days prior to the date of vesting. The value of each of the employee's J shares on vesting is calculated with reference to the gain in market capitalisation of Alpha between the allotment date (£761 million) and the vesting date (based on an average of the closing price of Alpha over 60 days prior to the date of vesting, subject to a cap of £1,694 million) divided by the number of relevant Alpha FX Limited shares in issue at the date of vesting.

 

L Share Growth Scheme

 

The Group will be adopting a new growth share scheme, under which 820 ordinary shares ("L Shares") in Alpha FX Limited will be issued in total to certain employees of the Group ("L Share Growth Scheme"). The L Share Growth Scheme will replace the existing G Growth Share Scheme and H Share Growth Scheme launched in 2022 and ensures that employees within the UK Corporate division are part of a single unified scheme.

 

The L Shares contain a put option, allowing the holder to convert their L shares into ordinary shares in Alpha. The L Shares allocated to each employee will vest in five equal tranches, occurring annually, in respect of the Financial Years for 2024, 2025, 2026, 2027 and 2028, subject to the London Corporate division (and the corporate division in Spain) achieving the target growth rates for that year. The relevant target growth rates are as follows:- London Corporate division (and the corporate division in Spain) revenue growth of 15% in Financial Year 2024, 15% in Financial Year 2025, 15% in Financial Year 2026, 10% in Financial Year 2027 and 10% in Financial Year 2028. Once vested the employee has the right to exercise their put option to convert their L shares into ordinary shares of Alpha. The number of ordinary shares of Alpha issued to the employees is calculated by dividing the value of the employee's holding of L shares by the average of the closing price of Alpha over 60 days prior to the date of vesting. The value of each of the employee's L shares on vesting is calculated with reference to the gain in market capitalisation of Alpha between the allotment date (£761 million) and the vesting date (based on an average of the closing price of Alpha over 60 days prior to the date of vesting, subject to a cap of £1,694 million) divided by the number of relevant Alpha FX Limited shares in issue at the date of vesting.

 

Fund Finance Share Scheme

Following the launch of the Fund Finance division in 2023, the Group is putting in place an employee share ownership scheme for certain individuals (the "Fund Finance Participants"). A new class of shares ("K Shares") in Alpha FX Limited is being created, with 75% owned by the Group and 25% owned by the remaining Fund Finance Participants. The value of the K Shares will be linked to the performance of the Fund Finance division. From March 2026, the Fund Finance Participants will have the option to convert 25% of their holding of K Shares into ordinary shares in the Company each year for four years (with the final option being exercisable in March 2029). The value of the shares upon conversion is based on an 8x multiple of the operation's annual profit after tax, and therefore is designed to be accretive on an EPS basis for our Group shareholders as long as Alpha's valuation stays in excess of an 8x multiple of earnings and Group earnings continue to grow sufficiently.

Italy Share Scheme

In order to incentivise the key personnel within the Italian Branch of Alpha FX Europe Limited, the Group is putting in place an employee share ownership scheme for certain individuals (the "Italy Branch Participants"). A new class of shares ("Class A Shares") in Alpha FX Europe Limited is being created, with 82.5% owned by the Group and 17.5% owned by the remaining Italy Branch Participants. The value of the Class A Shares will be linked to the performance of the Italian Branch of Alpha FX Europe Limited. From March 2026, the Italy Branch Participants will have the option to convert 25% of their holding of Class A Shares into ordinary shares of the Company each year for four years (with the final option being exercisable in March 2029). The value of the shares upon conversion is based on an 8x multiple of the operation's annual profit after tax, and therefore is designed to be accretive on an EPS basis for our Group shareholders as long as Alpha's valuation stays in excess of an 8x multiple of earnings and Group earnings continue to grow sufficiently.

Netherlands and Germany Option Scheme

 

In order to incentivise the key personnel within the German Branch of Alpha FX Europe Limited and within Alpha FX Netherlands Limited, the Group is putting in place two new employee option schemes for certain individuals. The option schemes are being launched under the terms of Alpha's new Group Incentive Plan that has been put in place as part of the move to the Main Market. The options are being granted over shares in Alpha and the number of options awarded are linked to the performance of the German Branch of Alpha FX Europe Limited and Alpha FX Netherlands Limited, respectively. The German option scheme will entitle holders to exercise 25% of their options into ordinary shares in the Company from March 2027 each year for four years (with the final option being exercisable in March 2030). The Netherlands option scheme will entitle holders to exercise 25% of their options into ordinary shares in the Company from March 2026 each year for four years (with the final option being exercisable in March 2029).

 

Alpha confirms that no shares or options have been granted to any executive director in connection with the above schemes.

 

Alpha further confirms that in order to maintain good corporate governance, it will include the shares issued in connection with the above share and option schemes when assessing its share plan dilution limit post admission to the Main Market.

 

135 of the L Shares are being issued to Alex Howorth, who is a PDMR of the Company, and therefore the relevant regulatory disclosure has been made in the table below.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Alex Howorth 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Group Managing Director, FX Risk Management

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Alpha Group International plc

b)

 

LEI

 

 

213800RESM1FPUXY6K31

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

L ordinary shares in Alpha FX Limited, which may be convertible into ordinary shares in Alpha Group International plc

Identification code

ISIN: GB00BF1TM596

b)

 

Nature of the transaction

 

 

Issue of L Shares

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

N/A

135 L Shares

d)

 

Aggregated information

N/A

- Aggregated volume

- Price

e)

 

Date of the transaction

 

 

26 April 2024

f)

 

Place of the transaction

 

 

Off market

 

 

Enquiries:

 

Alpha Group International plc

Morgan Tillbrook, Founder and CEO

Tim Powell, CFO

Via Alma

 

 

Liberum (Nominated Adviser and Joint Broker)

Max Jones

Ben Cryer

Anake Singh

 

+44 (0) 20 3100 2000

 

 

Peel Hunt (Joint Broker)

Neil Patel

Paul Gillam

Kate Bannatyne

 

+44 (0) 20 7418 8900

 

Alma Strategic Communications

(Financial Public Relations)

Josh Royston

Andy Bryant

Kieran Breheny

 

+44 (0) 20 3405 0205

 

 

Notes to editors

Alpha is a high-tech, high-touch provider of enhanced financial solutions dedicated to corporates and institutions globally. Working with clients across 50+ countries, we blend intelligent human capabilities with new technologies to provide clients with an enhanced alternative to their bank, with solutions covering: FX risk management, global accounts mass payments, fund finance and bank management.

 

Key to our success is our team - over 400 people based across seven global offices, brought together by a high-performance culture and a partnership structure that empowers them to act as owners of our business.

 

Whilst we are an established business listed on the London Stock Exchange, we remain relentlessly focused on maintaining the same level of operational agility and client focus we had when we first started in 2009. This dynamic, combined with the passion of our people, have enabled us to make a substantial and enduring difference to our clients, and deliver a growth story to match.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHZZGZDLVNGDZG
Date   Source Headline
3rd May 20247:00 amRNSTransaction in Own Shares
2nd May 20248:00 amRNSReadmission - Alpha Group International plc
2nd May 20247:00 amRNSAIM Delisting and Admission to Main Market
2nd May 20247:00 amRNSTransaction in Own Shares
1st May 20245:03 pmRNSDirector/PDMR Dealing
1st May 20243:36 pmRNSShare Buyback Programme
1st May 20243:35 pmRNSResult of AGM & Director Appointment
30th Apr 20247:00 amRNSTransaction in Own Shares
29th Apr 20245:30 pmRNSAlpha Group International
29th Apr 202412:00 pmRNSPublication of Prospectus
29th Apr 20247:00 amRNSTransaction in Own Shares
26th Apr 202411:00 amRNSNew Share Schemes
26th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNSTransaction in Own Shares
23rd Apr 20245:05 pmRNSNotification of Major Holdings
23rd Apr 20247:01 amRNSClient Balances & Interest Rates, Quarterly Update
23rd Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20249:58 amRNSHolding(s) in Company
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20242:55 pmRNSUpdate re: application for Main Market admission
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20247:01 amRNSNotice of AGM & Posting of Annual Report
5th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 202410:15 amRNSDirector/PDMR Dealing
3rd Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSIntended application for admission to Main Market
2nd Apr 20247:00 amRNSTransaction in Own Shares
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:30 amRNSTransfer of Shares from Treasury
26th Mar 20247:00 amRNSTransaction in Own Shares
20th Mar 20247:01 amRNSBoard Changes
20th Mar 20247:00 amRNSFull Year Results
20th Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20247:00 amRNSTransaction in Own Shares
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.